Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Ensem Therapeutics
Atavistik Bio, Inc
Ataturk University
Mayo Clinic
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
University College Cork
Bayer
Convalife (Shanghai) Co., Ltd.
Eastern Cooperative Oncology Group
Eli Lilly and Company
ViroMissile, Inc.
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Kaiser Permanente
AstraZeneca